Direct Sellers Update: Regulation, Law & Policy

The Federal Trade Commission (FTC) has taken yet another step in its campaign against misleading and deceptive claims. Recently, the FTC sent notice letters to hundreds of businesses with a clear warning: avoid making deceitful and/or unsubstantiated product claims or face substantial civil penalties. The notice has significant implications for direct sellers, particularly those involved in the marketing of over-the-counter (OTC) drugs, homeopathic products, dietary supplements, or functional foods. Let's take a closer look at the impact of this FTC notice on recipients.